Is Merck & Co., Inc. overvalued?

Merck & Co., Inc. (MRK) looks fairly valued — trading about 10% below its fair value.

Fairly valued

Price

$128.38

Fair value

$141.50

Current P/E

17.6

Normal P/E

19.4

Market cap

$317.08B

Dividend yield

3.1%

Return on equity

34.7%

Sector

Healthcare

Fair value compares MRK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks